menu search

JANX / Wall Street Analysts Believe Janux Therapeutics, Inc. (JANX) Could Rally 120.65%: Here's is How to Trade

Wall Street Analysts Believe Janux Therapeutics, Inc. (JANX) Could Rally 120.65%: Here's is How to Trade
The consensus price target hints at a 120.7% upside potential for Janux Therapeutics, Inc. (JANX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. Read More
Posted: Jul 20 2023, 11:27
Author Name: Zacks Investment Research
Views: 102031

JANX News  

All You Need to Know About Janux Therapeutics, Inc. (JANX) Rating Upgrade to Buy

By Zacks Investment Research
July 20, 2023

All You Need to Know About Janux Therapeutics, Inc. (JANX) Rating Upgrade to Buy

Janux Therapeutics, Inc. (JANX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This m more_horizontal

Wall Street Analysts Believe Janux Therapeutics, Inc. (JANX) Could Rally 120.65%: Here's is How to Trade

By Zacks Investment Research
July 20, 2023

Wall Street Analysts Believe Janux Therapeutics, Inc. (JANX) Could Rally 120.65%: Here's is How to Trade

The consensus price target hints at a 120.7% upside potential for Janux Therapeutics, Inc. (JANX). While empirical research shows that this sought-aft more_horizontal

Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Tops Revenue Estimates

By Zacks Investment Research
May 9, 2023

Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Tops Revenue Estimates

Janux Therapeutics, Inc. (JANX) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.49. This compare more_horizontal

Janux Therapeutics, Inc. (JANX) Surges 5.9%: Is This an Indication of Further Gains?

By Zacks Investment Research
February 14, 2023

Janux Therapeutics, Inc. (JANX) Surges 5.9%: Is This an Indication of Further Gains?

Janux Therapeutics, Inc. (JANX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate re more_horizontal

Janux Therapeutics to Present at Upcoming March Investor Conferences

By Business Wire
March 1, 2022

Janux Therapeutics to Present at Upcoming March Investor Conferences

SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a biopharmaceutical company developing a broad pipeline of novel immunoth more_horizontal

Janux Therapeutics to Present at Upcoming March Investor Conferences

By Business Wire
March 1, 2022

Janux Therapeutics to Present at Upcoming March Investor Conferences

SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a biopharmaceutical company developing a broad pipeline of novel immunoth more_horizontal

Janux Therapeutics to Present at Upcoming March Investor Conferences

By Business Wire
March 1, 2022

Janux Therapeutics to Present at Upcoming March Investor Conferences

SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a biopharmaceutical company developing a broad pipeline of novel immunoth more_horizontal


Search within

Pages Search Results: